Mechanisms and Clinical Trials of Hepatocellular Carcinoma Immunotherapy

Hepatocellular carcinoma (HCC), one of the most common and lethal tumors worldwide, is usually not diagnosed until the disease is advanced, which results in ineffective intervention and unfavorable prognosis. Small molecule targeted drugs of HCC, such as sorafenib, provided only about 2.8 months of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Genet
Autors principals: Huang, Shao-Li, Wang, Yu-Ming, Wang, Quan-Yue, Feng, Guang-Gui, Wu, Fu-Qing, Yang, Liu-Ming, Zhang, Xi-He, Xin, Hong-Wu
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Genetics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8296838/
https://ncbi.nlm.nih.gov/pubmed/34306031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2021.691391
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars